14.53 -0.04 (-0.27%)
4:07 PM ET 12/04/09
Company Profile
Price and Volume
Recent Price 14.57
52 Week High 27.00
52 Week Low 9.15
Avg. Daily Vol. (Mil) 0.30
Beta (3 year) -0.64
Share Related Items
Mkt Cap (Mil) 448.74
Shares Out (Mil) 30.80
Float (Mil) 17.13
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.70
Current Ratio 3.40
LT Debt/ Equity 0.09
Total Debt / Equity 0.17
Valuation Ratios
Price Earnings 16.20
Price/Sales 2.07
Price/Book 1.91
Price/Cash Flow 14.50
Per Share Data
Earnings 0.90
Sales 7.04
Book Value 7.64
Cash Flow 1.00
Business Summary
A biopharmaceutical company, which is focused on the development, manufacture and commercialization of vaccine and immune-related therapeutic that assist the bodys immune system to prevent or treat disease.
General Information
2273 Research Boulevard
Suite 400
Rockville, MD 20850
1.0
http://www.emergentbiosolutions.com
Industry : Drugs
Sector: Health Care
Employees: 587
CEO: Fuad El-Hibri
Short Interest
Current Month (Mil) 1.03
Previous Month (Mil) 0.89
Short Interest Ratio (Days) 2.60
Management Effectiveness
Return on Equity 11.00
Return on Assets 8.20
Return on Investments 10.10
Profitability
Gross Margin 83.30
EBIT Margin 16.50
Profit Margin 11.90
Dow Jones S&P 500 NASDAQ 10-Year Note
10,388.90 1,105.98 2,194.35 34.83
Oil *
77.74
UP
22.75
UP
6.06
UP
21.21
UP
1.03
10 Yr
3.48%
SPDR Gold
113.75
+0.22%
+0.55%
+0.98%
+3.05%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services